Comparative Bioavailability Study of Tablet and Granule Formulations of ADC189 and the Study of Ultra-high Dose

NCT06428903 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer

Interventions

DRUG: ADC189 tablet
DRUG: ADC189 granules
DRUG: ADC189 180mg

Sponsor

Jiaxing AnDiCon Biotech Co.,Ltd